Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is silevertinib, a brain-penetrant epidermal growth factor receptor MasterKey...
35 insider purchases on record · latest filing 2023-10-19.
Insiders have also filed 190 sale transactions at BDTX.